Microdosing candies recalled after psychoactive muscimol found
A recall was issued for Diamond Shruumz microdosing candies due to severe illnesses linked to psychoactive muscimol. Prophet Premium Blends acknowledged high muscimol levels, prompting the recall. FDA investigates undisclosed compounds. Consumers warned.
Read original article
A recall has been issued for Diamond Shruumz microdosing candies after reports of severe illnesses linked to the presence of psychoactive muscimol, a compound found in hallucinogenic Amanita muscaria mushrooms. The recall covers all lots and flavors of the brand's products following 39 reported cases of illness, including seizures, loss of consciousness, and hospitalizations across 20 states. The parent company, Prophet Premium Blends, acknowledged higher than normal levels of muscimol in the products, prompting the recall and cessation of production. The exact amounts of muscimol in the products remain unclear. The FDA is investigating the situation, including the presence of undisclosed synthetic psychedelic compounds and potentially toxic substances in the candies. Consumers are advised not to consume any Diamond Shruumz products and can return them for a refund. The CDC warns against consuming such "edibles" that may contain undisclosed and harmful ingredients, emphasizing terms like "microdosing" and "functional mushrooms" as red flags.
Related
Next-generation psychedelics: should new agents skip the trip?
Companies are investing in next-generation psychedelics to enhance mental health treatment, focusing on reducing psychoactive effects while maintaining therapeutic benefits. Despite expanding interest and investments, questions persist about efficacy and cost-effectiveness.
FDA warns top U.S. bakery not to claim foods contain allergens when they don't
The FDA warned Bimbo Bakeries USA for mislabeling allergens in their products. Advocates raised concerns about potential health risks for Americans with food allergies. Bimbo is cooperating with the FDA to rectify the issue by July 8.
Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier
Hims & Hers sells non-FDA approved weight loss drug through loophole, raising concerns about patient safety, legality, and supplier's history of fraud. Executives sold shares amid risks of legal consequences.
Synthetic psychedelic found in candies linked to seizures, intubation
A synthetic psychedelic compound and toxic plant compounds found in Diamond Shruumz candies caused severe illnesses in 39 cases across 20 states. FDA advises against consumption and is discussing a possible recall with the company.
Effects of psychedelics on neurogenesis and brain plasticity A systematic review
A systematic review examines psychedelics' impact on neurogenesis and brain plasticity, suggesting their potential in treating mood disorders. The study analyzed 205 articles, categorizing findings on various compounds' effects. It includes both experimental and human studies, aiming to inform new therapeutic approaches for neuropsychiatric conditions.
0 commentsRelated
Next-generation psychedelics: should new agents skip the trip?
Companies are investing in next-generation psychedelics to enhance mental health treatment, focusing on reducing psychoactive effects while maintaining therapeutic benefits. Despite expanding interest and investments, questions persist about efficacy and cost-effectiveness.
FDA warns top U.S. bakery not to claim foods contain allergens when they don't
The FDA warned Bimbo Bakeries USA for mislabeling allergens in their products. Advocates raised concerns about potential health risks for Americans with food allergies. Bimbo is cooperating with the FDA to rectify the issue by July 8.
Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier
Hims & Hers sells non-FDA approved weight loss drug through loophole, raising concerns about patient safety, legality, and supplier's history of fraud. Executives sold shares amid risks of legal consequences.
Synthetic psychedelic found in candies linked to seizures, intubation
A synthetic psychedelic compound and toxic plant compounds found in Diamond Shruumz candies caused severe illnesses in 39 cases across 20 states. FDA advises against consumption and is discussing a possible recall with the company.
Effects of psychedelics on neurogenesis and brain plasticity A systematic review
A systematic review examines psychedelics' impact on neurogenesis and brain plasticity, suggesting their potential in treating mood disorders. The study analyzed 205 articles, categorizing findings on various compounds' effects. It includes both experimental and human studies, aiming to inform new therapeutic approaches for neuropsychiatric conditions.